LightPath Technologies Begins Sustained Delivery of Infrared Assemblies to European Defense Customer
UF startup LightPath Technologies, Inc. announced that it has begun sustained delivery of infrared lens assemblies per the terms of the October 2024 Letter of Intent from a European defense customer for active duty use in first-person view (FPV) drone applications.
RTI Surgical Transforms Into Evergen, a Leading CDMO in Regenerative Medicine
UF startup RTI Surgical unveils its new corporate identity as Evergen, signaling its strategic evolution into a premier Contract Development and Manufacturing Organization (CDMO) providing biosolutions in regenerative medicine.
Portage Biotech Announces Letter of Intent With Immunova for an Option To Acquire iOx Therapeutics, Ltd
UF startup Immunova, LLC, a private Connecticut-based biotechnology company, has entered into a Letter of Intent with Portage Biotech, Inc. to advance its novel immuno-oncology therapies for cancer treatment.
LightPath Technologies Introduces New Optical Gas Imaging Camera for Ammonia and SF6 Detection
UF startup LightPath Technologies announced a new version of its Optical Gas Imaging ("OGI") camera platform to detect fugitive ammonia and sulfur hexafluoride (SF6) emissions for industrial and manufacturing applications.
Source Agriculture Corp. Makes Strategic Investment in Ascribe Bioscience To Advance Sustainable Crop Protection Solutions
Source Agriculture Corp., an innovative agri-tech investment firm, announced a strategic investment in UF Startup Ascribe Bioscience, a cutting-edge company dedicated to developing sustainable crop protection solutions.
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer
UF Startup Cannabix Technologies Inc. reports that it has received a positive certification test report from the globally recognized laboratory CEcert GmbH, based in Germany, for its Breath Logix autonomous, wall-mounted alcohol breathalyzer device.
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
UF Startup RTI Surgical announced the enrollment of the first patient in ADMIRE, a study designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
UF Startup Kate Therapeutics, a gene therapy specialist, is being acquired by Novartis in a deal worth up to $1.1 billion. This acquisition aligns with Novartis’s efforts to deliver treatments for neuromuscular disorders and fits into the pharma’s strategy to expand its new modality pipeline, ensuring long-term business sustainability.
Kriya Announces Publication of Preclinical Data for Its Investigational AAV-FGF21 Gene Therapy Demonstrating Durable Reversal of Liver Fibrosis
UF Startup Kriya Therapeutics, a biopharmaceutical company developing gene therapies to address common diseases affecting millions of people around the world, announced the publication of preclinical data for its investigational AAV-FGF21 gene therapy.
Solid Biosciences To Present at the Jefferies London Healthcare Conference
Solid Biosciences Inc., a biotechnology company that acquired UF startup AavantiBio, announced that Bo Combo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present at the Jefferies London Healthcare Conference on November 20.
